跳至主要内容
临床试验/TCTR20220830003
TCTR20220830003招募中1 期

A study of the efficacy and safety of microneedle patch containing triamcinolone acetonide and hydrocortisone in the treatment of inflammatory acne

ational Research Council of Thailand0 个研究点目标入组 10 人开始时间: 2022年8月30日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Both male and female with age of 18 to 60 years old
  • 3. Have inflammatory papular/pustular acne with 5 mm in size or more, for at least 4 lesions on the face

排除标准

  • 1. receive topical corticosteroid or intralesional corticosteroid within 2 weeks before recruitment
  • 2. receive ablative or non-ablative laser therapy on the face within 2 weeks before recruitment
  • 3. receive oral corticosteroid within 8 weeks before recruitment
  • 4. have active contact dermatitis, rash, eczema or skin infection on the face where the treatment will be located
  • 5. History of triamcinolone, hydrocortisone, hyaluronic acid allergy or have severe intralesional corticosteroid injection adverse effects
  • 6. are in pregnancy or breastfeeding period
  • 7. are unable to promptly visit the office for follow-up session

研究者

发起方
ational Research Council of Thailand

相似试验

A study of the efficacy and safety of microneedle... | 临床试验